ATYR aTyr Pharma
- 3.250
- +0.100+3.17%
- 3.020
- -0.230-7.08%
aTyr Pharma News
aTyr Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Point72 Asset Management, L.P.(6.2%),Point72 Capital Advisors, Inc.(6.2%), etc.
aTyr Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Federated Hermes, Inc.(19.35%),Voting Shares Irrevocable Trust(19.35%), etc.
aTyr Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
aTyr Pharma | 10-Q: Q2 2024 Earnings Report
aTyr Pharma | 8-K: aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director SCHIMMEL PAUL
aTyr Pharma | 8-K: Current report
aTyr Pharma | UPLOAD: Others
aTyr Pharma | CORRESP: CORRESP
aTyr Pharma | UPLOAD: Others
4: Statement of changes in beneficial ownership of securities-Officer DENYES NANCY
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director COUGHLIN TIMOTHY
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Broadfoot Jill Marie
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Shukla Sanjay
aTyr Pharma | 8-K: Current report
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director CLARKE JOHN K
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director Gross Jane A
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director Lucas Svetlana
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director SCHIMMEL PAUL
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director Zaknoen Sara
Analysis
Price Target
No Data
No Data